The Washington Post has an article by Lena H. Sun about the Olympics:
More than a hundred prominent physicians, bioethicists, and scientists from around the world posted a letter urging World Health Organization Director-General Margaret Chan to exert pressure on Olympic authorities to move the 2016 Olympics from Rio de Janeiro, or delay the Games because of public health concerns over the Zika virus.
Brazil, which is hosting the Olympics and the Paralympics, is at the epicenter of the rapidly-evolving mosquito-borne epidemic.
The letter is signed by 150 individuals from more than a dozen countries, including Brazil, Japan, Israel, Russia, Sweden, South Africa, and the United States. It calls on the World Health Organization to convene an independent group to advise it and the International Olympic Committee, and for authorities to reconsider the decision to hold the Games in Rio.
"We are doing it to ask for an open, transparent discussion of the risks of holding the Olympics as planned in Brazil," said Arthur Caplan, a bioethicist at New York University and one of the letter's four authors, in an email explaining the reasoning behind the letter.
The group of scientists is not seeking "general assurance" from the World Health Organization, Caplan said. Instead, they want "a frank discussion among independent experts," he said. "If Rio is going to happen, the world deserves a full discussion of why and with what potential risks and liabilities," Caplan said.
The other authors are Lee Igel, an associate professor at New York University; Amir Attaran, a biologist and law professor at the University of Ottawa in Canada; and Christopher Gaffney, a senior research fellow at the University of Zurich in Switzerland, who studies the impact of major sporting events on urban populations. Each author has published articles in recent weeks and months calling for the Games to be postponed because of Zika.
In the open letter posted Friday, the authors said evidence shows that Brazil’s Zika strain has more serious medical consequences than researchers previously knew, that Rio de Janeiro is one of the hardest-hit areas of the epidemic, and that Rio de Janeiro’s mosquito-killing efforts are not meeting expectations.
Zika infections during pregnancy can cause serious fetal brain abnormalities, including microcephaly, which is characterized by abnormally small heads and developmental problems. The virus has also been linked to neurological disorders in adults. Zika is primarily transmitted through mosquitoes, but can also spread through sexual contact.
In the most recent letter, the authors say that Rio de Janeiro’s public health system is so “severely weakened” as to make a last-minute push against the mosquito that transmits Zika impossible. Citing government data, the letter notes the increasing number of cases of dengue, a related virus spread by the same mosquitoes, that is considered a proxy for Zika.
In the specific neighborhood of the Olympic Park, Barra da Tijuca, there have been more dengue cases in the first quarter of 2016 than in all of 2015, the letter said. “It is therefore imperative that the World Health Organization conducts a fresh, evidence-based assessment of Zika and the Games, and its recommendations for travelers,” the letter said. “Given the public health and ethical consequences, not doing so is irresponsible.”
The International Olympic Committee insists that the Games will go forward as planned. Earlier this month, the World Health Organization urged athletes and travelers planning to attend the competitions to take measures to protect against infection, but did not call for the Olympics, which start on 5 August, or the Paralympics, which begin on 7 September, to be canceled or postponed.
Late Friday, the World Health Organization said that based on its current assessment, "cancelling or changing the location of the 2016 Olympics will not significantly alter the international spread of the Zika virus." It noted that Brazil is one of almost sixty countries and territories which have reported the continuing spread of Zika.
"People continue to travel between these countries and territories for a variety of reasons," the statement said. The best way to reduce risk of disease is to follow public health travel advice, the World Health Organization said. "There is no public health justification for postponing or cancelling the games," the World Health Organization said. The US Olympic Committee officials have said the decision to attend the Games is up to individual athletes.
The authors say the estimated half billion foreign tourists from all over the world who are expected to attend the Games represent an unnecessary risk because they could potentially get infected and return home to places where the virus can become endemic.
"Should that happen to poor, as-yet unaffected places (e.g., most of South Asia and Africa) the suffering can be great," the authors wrote. "It is unethical to run the risk, just for Games that could proceed anyway, if postponed and/or moved."
American health officials also disagree with the authors' assessment. In an interview this week, Tom Frieden, the director of the Centers for Disease Control and Prevention, said that “We don’t see from a public health standpoint any reason to cancel the Olympics." "There’s been some claims that, if the Olympics happen, it’s going to disseminate the virus everywhere, it’s going to amplify it," Frieden said. "Well, we looked at the numbers. The Olympics account for less than one quarter of one percent of all travel to Zika-affected areas." Frieden has said the risk to Olympians is "very, very low." About a hundred athletes, coaches and staff of the US Olympic delegation are already being monitored for the virus as they begin to go to Brazil; up to a thousand are expected to be monitored as the Olympics and Paralympics begin. He said it was "unfortunate" that Major League Baseball recently decided to scrap a two-game series in Puerto Rico and move it to Miami, Florida amid concerns over the Zika virus.
CDC and health officials across the globe have advised women who are pregnant to avoid traveling to regions where Zika is prevalent, and they have advised women who are trying to become pregnant, and their male partners, to use condoms or abstain from sex during their stay and for months after returning home.
The CDC is also conducting a risk assessment for each of the approximately two hundred countries with athlete delegations. More than ten thousand athletes are expected at the Olympics and about five thousand are likely to be at the Paralympics. Analysts are looking at the expected number of athletes and travelers likely to go to Brazil, the susceptibility of those countries to epidemic diseases, and the potential for how added travel might accelerate the spread of Zika.
But the letter's authors say the many uncertainties about Zika "currently make it impossible for mathematical models to predict the epidemic’s course accurately."
Here's a full list of the 150 people who signed the letter, in alphabetical order, and represent individuals, not their institutions:Rico says that, if they don't cancel, the worldwide disaster will be overwhelming. For Zika-infected pregnancies, the risk of microcephaly may be as high as thirteen percent. (And, once it happens and it's too fucking late, all those 'oh, no, things'll be fine' assholes will disappear...)
1. Professor Akira Akabayashi, Department of Biomedical Ethics, School of Public Health, the University of Tokyo Faculty of Medicine, Tokyo
2. Professor Paul S. Appelbaum, director, Division of Law, Ethics & Psychiatry, Department of Psychiatry, Columbia University, New York
CONTENT FROM SAMSUNG
Connectivity for a smarter world
The Internet of Things (IoT) has the potential to solve our biggest global challenges and bring people everywhere a better quality of life.
3. Professor Kwame Anthony Appiah, Department of Philosophy, NYU Law, New York University, New York
4. Professor Thalia Arawi, founding director, Salim El-Hoss Bioethics & Professionalism Program, Faculty of Medicine, American University of Beirut, Beirut
5. Professor Amir Attaran, School of Epidemiology, Public Health and Community Medicine and Faculty of Law, University of Ottawa, Canada
6. Stephanie Augustine, researcher, Department of Maternal Fetal Medicine, North Shore University Hospital, Manhasset, N.Y.
7. Professor Robert Baker, Bioethics Program of Clarkson University & the Icahn School of Medicine at Mount Sinai, Schenectady, N.Y.
8. Alison Bateman-House, Division of Medical Ethics, Department of Population Health, New York University School of Medicine, New York
9. Professor Frances Batzer, Department of Obstetrics & Gynecology, Thomas Jefferson University, Philadelphia
10. Professor Angelica M. Baylon, external relations director, Maritime Academy of Asia, Kamaya Point, Philippines
11. Professor Solly Benatar, founding director, University of Cape Town Bioethics Center, Department of Medicine, University of Cape Town, Cape Town, South Africa
12. Professor Cecilia Benoit, Center for Addictions Research of British Columbia, Department of Sociology, University of Victoria, Victoria, Canada
13. Edward J. Bergman, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
14. Professor Kenneth Berkowitz, Department of Population Health and Department of Medicine, School of Medicine, New York University, New York
15. Professor Ivy Lynn Bourgeault, Canadian Institutes of Health Research chair in gender, work and health human resources, Telfer School of Management, University of Ottawa, Ottawa
16. Professor Marie A. Bragg, Department of Population Health, New York University School of Medicine, New York
17. Berit Bringedal, senior researcher, Institute for Studies of the Medical Profession, Oslo
18. Professor Amy Brown, Maria Fareri Children’s Hospital at Westchester Medical Center, Department of Pediatrics, New York Medical College, Valhalla, N.Y.
19. Professor Arthur L. Caplan, Division of Medical Ethics, New York University Langone Medical Center, New York
20. Rhyddhi Chakraborty, researcher, philosophical bioethics, global public health and social justice, American University of Sovereign Nations, United States.
21. Professor Theeraphap Chareonviriyaphap, Department of Entomology, Kasetsart University, Bangkok
22. Professor Cheryl Cline, Office of Bioethics, Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Canada.
23. Catherine Constable, instructor, Department of Medicine, New York University Langone Medical Center, New York
24. Professor Glenn Cohen, Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics, Harvard Law School, Cambridge, Mass.
25. Professor Patrick Derr, chair, Department of Philosophy, Clark University, Worcester, Mass.
26. Professor Débora Diniz, faculty of Law, Universidade de Brasilia, and Bioethics Program, FIOCRUZ, Brasilia and Rio de Janeiro
27. Professor Ames Dhai, director, Steve Biko Center for Bioethics, faculty of Health Sciences, University of the Witwatersrand, Johannesburg
28. Hasan Erbay, MD, PhD, Department of Medical Ethics and History of Medicine, Afyon Kocatepe University Faculty of Medicine, Afyonkarahisar, Turkey
29. Professor Eric Feldman, Health Policy and Medical Ethics, University of Pennsylvania Law School, Philadelphia
30. Holly Fernandez-Lynch, executive director, Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, Harvard University, Cambridge, Mass.
31. Professor Chris Feudtner, Department of Pediatrics and Department of Medical Ethics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
32. Christopher Gaffney, Department of Geography, University of Zurich, Zurich
33. Professor William Gardner, Children’s Hospital of Eastern Ontario Research Institute, faculty of Medicine, University of Ottawa, Ottawa
34. Professor Robert P. George, McCormick professor of jurisprudence, Princeton University, Princeton, N.J.
35. Professor Grover Gilmore, dean, applied social sciences, Case Western Reserve University, Cleveland
36. Professor Moti Gorin, director, Jann Benson Ethics Center, Colorado State University, Fort Collins, Colo.
37. Professor Linda Granowetter, Department of Pediatrics, New York University Langone Medical Center, New York
38. Professor Abhik Gupta, PhD, professor and dean, School of Environmental Sciences, Assam (Central) University, Silchar, India
39. Professor Sally Guttmacher, College of Global Public Health, New York University, New York
40. Professor Negin Hajizadeh, Department of Medicine, Hofstra Northwell School of Medicine, Hofstra University, Hempstead, N.Y.
41. George Halvorson, retired chief executive, Kaiser Permanente, and chair, InterGroup Understanding, Sausalito, Calif.
42. Professor Deborah S. Hamm, Department of Psychiatry, Columbia University Medical Center, New York
43. Professor Alice Herb, Division of Humanities in Medicine at State University of New York, Downstate Medical Center, New York
44. Professor Søren Holm, Center for Social Ethics and Policy, School of Law, University of Manchester, United Kingdom
45. Professor Lee H. Igel, Tisch Institute for Sports Management, Media, and Business, New York University, New York
46. Professor Judy Illes, Canada research chair in neuroethics, Department of Medicine, University of British Columbia, Vancouver, Canada
47. Mahmood-uz- Jahan, MD, PhD, director, Bangladesh Medical Research Council, Dhaka, Bangladesh
48. Professor Dale Jamieson, chair, Department of Environmental Studies, New York University, New York
49. Professor Yeremias Jena, master of philosophy, master of science, professor of medical ethics at Atma Jaya School of Medicine, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
50. Professor Steven Joffe, vice chair, Department of Medical Ethics and Health Policy, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia
51. Professor Ken Johnson, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Canada
52. Professor Nora Jones, associate director, Center for Bioethics, Urban Health, and Policy, Lewis Katz School of Medicine, Temple University, Philadelphia
53. Professor Therese Jones, associate director, Center for Bioethics and Humanities, director, Arts and Humanities in Healthcare Program, University of Colorado Anschutz Medical Campus, Denver
54. Professor Matthias A. Karajannis, Division of Pediatric Hematology/Oncology, New York University Langone Medical Center, New York
55. Professor Douglas I. Katz, Department of Neurology, Boston University School of Medicine, Braintree, Mass.
56. Professor Ralph V. Katz, professor of epidemiology, Fellow of the American College of Epidemiology (FACE), and founding chair, Department of Epidemiology and Health Promotion, New York University, New York
57. Lisa Kearns, research associate, Division of Medical Ethics, New York University Langone Medical Center, New York
58. Professor Aaron Seth Kesselheim, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, Harvard University, Boston
59. Abbas Kharabi, University of Malaya, Kuala Lumpur, Malaysia
60. Robert Klitzman, professor of psychiatry, director, Masters of Bioethics Program Columbia University, New York
61. Professor Craig Klugman, chair, Department of Health Sciences, DePaul University, Chicago
62. Professor Adam Kolber, Center for Health, Science, and Public Policy, Brooklyn Law School, Brooklyn, New York
63. Professor Craig Konnoth, senior fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania Law School, Philadelphia
64. Professor Ralph A. Korpman, School of Medicine, Loma Linda University School of Medicine, Loma Linda, Calif.
65. Ronald L. Krall, Center for Bioethics and Health Law, University of Pittsburgh, Pittsburgh
66. Professor Sheldon Krimsky, Department of Urban and Environmental Policy & Planning, Department of Health and Community Medicine, Tufts University, Boston
67. Professor John Lantos, director of pediatric bioethics, Department of Pediatrics, University of Missouri at Kansas City School of Medicine, Kansas City, Mo.
68. Professor John Last, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa
69. Professor Stephen Latham, director, Interdisciplinary Center for Bioethics, Yale University, New Haven, Conn.
70. Thuy Le, Oxford University Clinical Research Unit, Oxford University, Ho Chi Minh City, Vietnam
71. Professor Arthur Leader, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa
72. Leonard leBlanc, research fellow, Eubios Ethics Institute, Japan
73. Professor Trudo Lemmens, Scholl Chair in Health Law and Policy, Faculty of Law, University of Toronto, Toronto
74. Professor Betty Wolder Levin, School of Public Health and Health Policy, City University of New York, New York
75. Professor Bruce Levin, Department of Biostatistics, Mailman School of Public Health, Columbia University, New York
76. Professor Ariane Lewis, Department of Neurology and Department of Neurosurgery, New York University Langone Medical Center, New York
77. Ana Lita, director, Global Bioethics Initiative, New York
78. Professor Julian Little, director, School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa
79. Professor Sergio Litewka, Institute for Bioethics and Health Policy, Miller School of Medicine, University of Miami, Miami
80. Professor Alex John London, director, Center for Ethics and Policy, Carnegie Mellon University, Pittsburgh
81. Darryl Macer, PhD, honorary degree, president, American University of Sovereign Nations, Arizona; director, Eubios Ethics Institute, Christchurch, New Zealand
82. Professor Tim Mackey, director, Global Health Policy Institute, Department of Anesthesiology and Public Health, University of California at San Diego, San Diego
83. Professor Ruth Macklin, Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Yeshiva University, New York
84. Professor Cheryl Macpherson, Bioethics Department, St George’s University School of Medicine, True Blue, Grenada
85. Professor Brian Martin, director, graduate program in public health, Eastern Virginia Medical School, Old Dominion University, Norfolk, Va.
86. Professor Thomas Mayo, Southern Methodist University Dedman School of Law, University of Texas Southwestern Medical School, Dallas
87. Michael Mawadri, emergency coordinator with Action for Development (AFOD) in South Sudan
88. Professor James McCartney (Reverend, Order of St. Augustine), Department of Philosophy, Villanova University, Villanova, Penn.
89. Professor John Merz, Department of Medical Ethics & Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
90. Alan Milstein, sports attorney, Sherman, Silverstein, Kohl, Rose & Podolsky, Moorestown, N.J.
91. Professor Christine Mitchell, executive director, Center for Bioethics, Harvard Medical School, Boston
92. Professor Jonathan D. Moreno, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
93. Professor Martin Müller, Department of Geography, University of Zurich, Zurich
94. Professor Carin Muhr, Department of Medical Science, Uppsala University, Uppsala, Sweden.
95. Professor Anna Nolan, Department of Environmental Medicine , Department of Medicine, New York University Langone Medical Center, New York
96. Professor Stjepan Oreskovic, Andrija Stampar School of Public Health, University of Zagreb School of Medicine, Zagreb, Croatia
97. Professor Brendan Parent, Division of Medical Ethics, and co-director, NYU Sports and Society Program, New York University, New York
98. Professor Shamina Parvin Lasker, head of Department of Anatomy, Samorita Medical College; secretary general, Bangladesh Bioethics Society, Dhaka, Bangladesh
99. Professor Pasquale Patrizio, Division of Reproductive Endocrinology & Infertility, Yale School of Medicine, New Haven, Conn.
100. Professor Sean Philpott-Jones, Department of Bioethics, Clarkson University, Schenectady, N.Y.
101. Carolyn Plunkett, Division of Medical Ethics, New York University Langone Medical Center, New York
102. Professor Stephen G. Post, Department of Family, Population & Preventive Medicine, Stony Brook University School of Medicine, Stony Brook, N.Y.
103. Professor Kathleen Powderly, director, John Conley Division of Medical Ethics and Humanities, SUNY Downstate Medical Center, Brooklyn, N.Y.
104. Professor Duncan Purves, Environmental Studies and Bioethics, New York University, New York
105. Professor Vojin Rakic, founding director, Center for the Study of Bioethics, Head of the European Division of the UNESCO Chair in Bioethics, University of Belgrade, Serbia
106. Professor Vardit Ravitsky, School of Public Health, Université de Montréal, Montreal
107. Professor Avad Raz, Department of Sociology and Anthropology, Ben-Gurion University of the Negev, Be’er-Sheva, Israel
108. Professor Kathleen Reeves, eirector, Center for Bioethics, Urban Health, and Policy, Lewis Katz School of Medicine, Temple University, Philadelphia
109. Professor Donald R. Roberts, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Md.
110. Philip Rubin, retired principal assistant director, Office of Science and Technology Policy (OSTP), Executive Office of the President of the United States, New Haven, Conn.
111. Professor William Ruddick, founding director, Center for Bioethics, New York University, New York
112. Professor Maya Sabatello, Department of Psychiatry, Columbia University, New York
113. Mojgan Saleuhipour, faculty of Biomedicine, South Baylo University, Calif.
114. Professor Judit Sandor, director of the Center for Ethics and Law in Biomedicine, Central European University, Budapest
115. Professor Pamela L. Sankar, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
116. Professor Arthur Schaefer, founding director, Center for Professional and Applied Ethics, University of Manitoba, Canada
117. Professor Udo Schuklenk, Ontario Research Chair in Bioethics, Department of Philosophy, Queen’s University, Kingston, Canada
118. Professor Evan Selinger, Department of Philosophy, Rochester Institute of Technology, Rochester, N.Y.
119. M. Selvanayagam, professor, dean of research and president of India Association of Bioethics, India
120. Professor Seema K. Shah, Department of Pediatrics, University of Washington School of Medicine, Seattle
121. Professor William S. Silvers, University of Colorado Denver School of Medicine, Denver
122. Professor Peter Singer, University Center for Human Values, Princeton University, Princeton, N.J.; and School of Historical and Philosophical Studies, University of Melbourne, Melbourne, Australia
123. Professor Maria Fiatarone Singh, chair of exercise and sport science, Faculty of Health Sciences, Sydney Medical School, University of Sydney, Australia
124. Professor Daniel Skinner, assistant professor of Health Policy, Department of Social Medicine, Ohio University, Dublin, Ohio
125. Raquel R. Smith, PhD, professor of clinical psychology, American University of Sovereign Nations, Arizona; FEMA Community Emergency Response Team instructor and manager
126. Professor Robert Smith, Department of Mathematics and Faculty of Medicine, University of Ottawa, Ottawa
127. Professor Jeremy Snyder, faculty of Health Science, Simon Fraser University, Burnaby, Canada
128. Professor Robert W. Snyder, Esq., attorney at law, professor of health-care management and finance, American University of Sovereign Nations School of Medicine, Arizona
129. Professor Martin Strosberg, Bioethics Program of Clarkson University & the Icahn School of Medicine at Mount Sinai, Schenectady, N.Y.
130. Professor Eileen Sullivan-Marx, dean, School of Nursing, New York University, New York
131. Professor Edwin van Teijlingen, Center for Midwifery, Maternal & Perinatal Health, Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, U.K.
132. Professor Henk ten Have, director, Center for Healthcare Ethics, Duquesne University, Pittsburgh
133. Ananya Tritipthumrongchok, general manager, International Peace and Development Ethics Center, Kaeng Krachan, Thailand
134. Professor Duunjian Tsai, MD, PhD, professor, Taipei Medical University, Taiwan
135. Professor Connie Ulrich, Department of Biobehavioral Health Sciences, University of Pennsylvania School of Nursing, Philadelphia
136. Professor Erick Valdés, Universisad del Desarrollo, Chile
137. Professor Robert M. Veatch, Kennedy Institute of Ethics, Georgetown University, Washington, D.C.
138. Professor J. David Velleman, professor of philosophy and bioethics, New York University, New York
139. Ford Vox, Brain Injury Medicine, Shepherd Center, Atlanta
140. Gary I. Wadler, past chairman, World Anti-Doping Agency (WADA) Prohibited List Committee, recipient of the International Olympic Committee’s President’s Prize in 1993, Manhasset, NY.
141. Wendell Wallach, lecturer, Yale Interdisciplinary Center for Bioethics, New Haven, Conn.
142. Professor Vivian Welch, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa
143. Professor Bruce Wilcox, faculty of Public Health, Mahidol University, Bangkok
144. Professor Benjamin Wilfond, director, Treuman Katz Center for Pediatric Bioethics, Seattle Children’s Research Institute, Department of Pediatrics, University of Washington, Seattle
145. Professor Loren Wissner Greene, Department of Population Health and Bioethics, Department of Obstetrics and Gynecology, New York University Langone Medical Center, New York
146. Professor Wendy L. Wobeser, Division of Infectious Diseases, Queen’s University, Kingston, Canada
147. Professor Paul Root Wolpe, Asa Griggs Candler Professor of Bioethics, and director, Center for Ethics, Emory University, Atlanta
To Your Health newsletter
Health news and research, in your inbox weekly.
Sign up
148. Professor Sanni Yaya, School of International Development and Global Studies, Faculty of Social Sciences, University of Ottawa, Ottawa
149. Professor Boris Yudin, Department of Humanitarian Expertise and Bioethics, Institute of Philosophy, Russian Academy of Sciences, Moscow
150. Diana Zuckerman, president, National Center for Health Research, Washington, D.C.
Pregnant women infected with the Zika virus during their first trimester face as high as a thirteen percent chance that their fetus will develop a severe and rare brain defect, according to research published Wednesday.Rico says we fail to remember that Mother Nature, a power hitter, always bats last...
That condition, known as microcephaly (photo), is characterized by an abnormally small head and often incomplete brain development. Researchers at the Centers for Disease Control and Prevention and the Harvard T.H. Chan School of Public Health identified the sharply higher risk after analyzing data from one of the hardest hit areas in Brazil, the epicenter of the rapidly evolving Zika outbreak.
Typically, microcephaly occurs in .02 percent to .12 percent of all US births. The prevalence of even more common congenital conditions, such as Down syndrome, is often less than one percent. By contrast, the study published in the New England Journal of Medicine found the estimated risk for microcephaly with Zika infections in the first trimester of pregnancy ranged from one to thirteen percent.
The analysis is the first to quantify such risk in pregnant women infected during the current outbreak, which has seen the mosquito-borne virus spread to more than forty countries and territories in the Americas and beyond. Recent testing showed the same strain is now on the African archipelago of Cape Verde.
"It is an appreciable risk," said Michael Johansson, a CDC biologist and lead author of the study. "We need to do whatever we can to help women avoid Zika virus infections during pregnancy." The study comes just weeks before the start of summer and mosquito season across the United States. Federal and local public health officials, particularly in the South and Southwest, are highly concerned about many communities' ability to track and prevent spread of the virus.
The CDC and Harvard researchers found a strong association between the risk of microcephaly and infection during the first trimester, but "a negligible association in the second and third trimesters". They were only able to provide a range of risk because of the significant uncertainty about the overall rate of Zika infection in the population studied and the accuracy of the microcephaly cases reported.
Much more research needs to be done about the effects of Zika at all stages of pregnancy, Johansson said, and other studies are now tracking hundreds of Brazilian women and babies.
No other countries where Zika is being transmitted locally have suffered the same spike in microcephaly, but that could change soon. "If the risk of infection and adverse outcomes is similar in the other geographic areas where Zika virus has since spread, many more cases of microcephaly and other adverse outcomes are likely to occur," the study warned. It urged health care systems "to prepare for an increased burden of adverse pregnancy outcomes in the coming years."
The CDC is monitoring three hundred pregnant women infected with Zika in the United States, while Brazil has recorded nearly four thousand pregnant women with Zika since January. Since the outbreak began there last year, more than fourteen hundred cases of microcephaly and other fetal neurological disorders have been confirmed.
Last month, CDC scientists confirmed that the virus causes microcephaly and other severe fetal abnormalities during pregnancy, but researchers don't know the full magnitude of that risk. Some infected women have given birth to healthy babies.
An analysis of a 2013-2014 Zika outbreak in French Polynesia estimated the risk for microcephaly to be around one percent for pregnant women infected in their first trimester. But that estimate, from the single outbreak, was based on microcephaly cases identified after the fact.
Speaking to reporters May 20, President Obama said members of Congress should not leave for their recess until they pass "a bill that has sufficient funds to" fight the spread of the Zika virus effectively. Researchers in the current study analyzed the approximate number of suspected Zika cases reported in Bahia, Brazil from February of 2015 to this past February and the number of reported and estimated microcephaly cases from January of 2015 to February of 2016. They then calculated the estimated microcephaly risk by comparing estimated infection risk in each trimester to microcephaly incidence. The first trimester of pregnancy was linked with the highest risk, they found.
An earlier study with ninety women at one clinic in Rio de Janeiro found that thirty percent of women who had ultrasounds after testing positive for Zika had fetuses with "grave" complications, extending beyond microcephaly to brain calcifications and vision problems. Some fetal problems had not been seen previously, including damage to central nervous systems and a lack of amniotic fluid by late pregnancy.
In the current study, researchers were trying to learn more about the effects of Zika infection in early pregnancy, when women might not even know they were expecting. Hospital or clinic-based studies only capture women with actual viral symptoms, Johansson said.
The CDC and Brazilian researchers are also conducting a case-control investigation involving infected women who have delivered healthy babies and who have given birth to babies with microcephaly. They want to better understand the relative risk the virus is playing in the condition there.
No comments:
Post a Comment
No more Anonymous comments, sorry.